The Effect of Short-Term Estradiol Therapy on Cognitive Function in Older Men Receiving Hormonal Suppression Therapy for Prostate Cancer

Authors: Taxel, Pamela1; Stevens, Michael C.2; Trahiotis, Margaret3; Zimmerman, Jill3; Kaplan, Richard F.4

Source: Journal of the American Geriatrics Society, Volume 52, Number 2, February 2004 , pp. 269-273(5)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

See editorial comments by Dr. Sanjay Asthana on pp 316-318. Objectives:

To determine the effect of estrogen (E) alone (without the influence of testosterone (T)) on cognitive function in older men, using 17-β micronized estradiol versus placebo in older men rendered hypogonadal (low T and E) by treatment for prostate cancer. Design:

Short-term double-blind, randomized, controlled trial. Setting:

An outpatient General Clinical Research Center. Participants:

Twenty-seven community-dwelling men aged 65 and older receiving neoadjuvant or established therapy with luteinizing-hormone releasing-hormone agonists for treatment of prostate cancer enrolled in a short-term randomized, controlled trial of 17-β micronized estradiol versus placebo on the effect on biochemical markers of bone turnover. Measurements:

Hormone levels, including E, T, and sex hormone-binding globulin; standardized neurocognitive tests, including measures of sustained attention, executive function, and memory; and questionnaires to assess subjects' perception of cognitive deficits and symptoms of depression. Results:

There were no significant differences between patients receiving E or placebo on 15 of 17 neurocognitive measures and no significant differences in self-reported cognitive deficits or number of depressive symptoms. Conclusion:

Although studies have suggested that E replacement therapy may improve cognitive function, most notably memory performance in postmenopausal woman, there was no evidence in the present study that the addition of short-term E therapy was more beneficial than placebo in tests of cognitive performance in hypogonadal men.

Keywords: estrogen; cognitive function; older men; estradiol

Document Type: Research article

DOI: 10.1111/j.1532-5415.2004.52067.x

Affiliations: 1: Division of Endocrinology and Metabolism and Center on Aging; 2: Olin Neuropsychiatry Research Center, Yale University School of Medicine, New Haven, Connecticut. 3: General Clinical Research Center, University of Connecticut Health Center, Farmington, Connecticut; and 4: Division of Psychiatry;

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A